Abstracts tagged "Decision analysis"

Abstract Number: 2635 • 2012 ACR/ARHP Annual Meeting
Exploring the Influence of Patient Perceptions On Medication Escalation in Daily Practice
Jos Hendrikx¹, Wietske Kievit², Jaap Fransen² and Piet L.C.M. van Riel², ¹Rheumatology (470), Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, ²Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Background/Purpose: In rheumatoid arthritis (RA), patients' and physicians' perceptions of disease can differ and patients who are satisfied with their health do not tend to…
Abstract Number: 2509 • 2012 ACR/ARHP Annual Meeting
Cost-Effectiveness of Training Rural Providers to Perform Joint Injections
Michael J. Battistone¹, Richard E. Nelson², William D. Ashworth³, Andrea Barker³, Marissa Grotzke⁴, Timothy A. Huhtala⁵, Robert Z. Tashjian⁶ and Grant W. Cannon¹, ¹Division of Rheumatology, Salt Lake City VA and University of Utah, Salt Lake City, UT, ²Division of Epidemiology, Salt Lake City VA and University of Utah, Salt Lake City, UT, ³General Internal Medicine, Salt Lake City VA and University of Utah, Salt Lake City, UT, ⁴Division of Endocrinology, Salt Lake City VA and University of Utah, Salt Lake City, UT, ⁵Division of General Internal Medicine, Salt Lake City VA and University of Utah, Salt Lake City, UT, ⁶Division of Orthopaedics, Salt Lake City VA and University of Utah, Salt Lake City, UT
Background/Purpose: Community based outpatient clinics (CBOCs) have been established by the Department of Veteran Affairs (VA) to provide primary care services to veterans living in…
Abstract Number: 2463 • 2012 ACR/ARHP Annual Meeting
Cost-Effectiveness of Tocilizumab Monotherapy Vs. Adalimumab Monotherapy in the Treatment of Severe Active Rheumatoid Arthritis
Josh J. Carlson¹, Sarika Ogale², Fred Dejonckheere³ and Sean Sullivan⁴, ¹Pharmacy, University of Washington, Seattle, WA, ²Genentech, South San Francisco, CA, ³F. Hoffmann-La Roche Ltd, Basel, Switzerland, ⁴Health Sciences Building, University of Washington, Seattle, WA
Background/Purpose: The ADACTA trial found that biologic naïve patients with severe active RA who are methotrexate (MTX) intolerant or in whom continued MTX treatment is…
Abstract Number: 2440 • 2012 ACR/ARHP Annual Meeting
Decisional Conflict Among Vulnerable Patient Populations with Rheumatoid Arthritis Is Associated with Limited Health Literacy and Non-English Language
Laura Trupin¹, Jennifer Barton¹, Gina Evans-Young¹, John B. Imboden¹, Andrew J. Gross², Dean Schillinger³ and Edward H. Yelin⁴, ¹Rheumatology, UCSF, San Francisco, CA, ²Medicine, University of California, San Francisco, San Francisco, CA, ³Medicine and Center for Vulnerable Populations, UCSF, San Francisco, CA, ⁴Arthritis Research Group, University of California, San Francisco, San Francisco, CA
Background/Purpose: Suboptimal communication in shared decision-making among vulnerable populations has been reported in rheumatoid arthritis (RA). National and international recommendations for quality health care highlight…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].